WILMINGTON, Del., Feb. 12, 2016 -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Nobilis Health Corp. (NYSE:HLTH)?
- Did you purchase your shares between April 2, 2015 and January 6, 2016, inclusive?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. announces that a complaint has been filed in the United States District Court for the Southern District of Texas on behalf of all persons or entities that purchased the common stock of Nobilis Health Corp. (“Nobilis” or the “Company”) (NYSE:HLTH) between April 2, 2015 and January 6, 2016, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you purchased shares of Nobilis during the Class Period, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/nobilis-health-corp-hlth.
The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects. As a result of defendants’ alleged false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.
According to the Complaint, on November 11, 2015, post-market, Nobilis announced that its preliminary results for the third quarter of 2015 and the Company’s final earnings release would be delayed. Then, on January 5, 2016, post-market, Nobilis confirmed what the Company had strongly implied by failing to announce its quarterly earnings in November 2015. In its Form 8-K with the SEC, Nobilis disclosed that its financial statements for the fiscal year ended December 31, 2014, the quarters ended March 31, 2015 and June 30, 2015 and the financial statements in its updated S-1 registration statement filed with the SEC on October 23, 2015 could no longer be relied upon.
On this news, shares of Nobilis dropped over 20%, closing at $2.47 per share on January 7, 2016, on heavy trading volume.
If you wish to serve as lead plaintiff, you must move the Court no later than March 21, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com


U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Google Secures Pentagon AI Deal for Classified Projects
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 



